ArticleTargeted oncology2024

A Phase 1 Study of Intravenous EGFR-ErbituxEDVsMIT in Children with Solid or CNS Tumours Expressing Epidermal Growth Factor Receptor.

Louise Evans et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.